According to The Insight Partners, the rheumatology market is broadly segmented by: Drug class: nonsteroidal anti‑inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease‑modifying anti‑rheumatic drugs (DMARDs). Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis. Distribution channels: hospital pharmacies, retail...